Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
Cipla
Covington
Fuji
Accenture
Farmers Insurance
Merck
Healthtrust
Chubb

Generated: December 16, 2018

DrugPatentWatch Database Preview

NORTHERA Drug Profile

« Back to Dashboard

When do Northera patents expire, and what generic alternatives are available?

Northera is a drug marketed by Lundbeck Na Ltd and is included in one NDA.

The generic ingredient in NORTHERA is droxidopa. There are six drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the droxidopa profile page.

Drug patent expirations by year for NORTHERA
Generic Entry Opportunity Date for NORTHERA
Generic Entry Date for NORTHERA*:
Constraining patent/regulatory exclusivity:
TREATMENT OF NEUROGENIC SYMPTOMATIC ORTHOSTATIC HYPOTENSION IN PATIENTS WITH PRIMARY AUTONOMIC FAILURE, DOPAMINE-BETA-HYDROXYLASE DEFICIENCY, AND NONDIABETIC AUTONOMIC NEUROPATHY
NDA:
Dosage:
CAPSULE;ORAL

*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.

Pharmacology for NORTHERA
Physiological EffectIncreased Blood Pressure
Medical Subject Heading (MeSH) Categories for NORTHERA
Synonyms for NORTHERA
(-)-(2S,3R)-2-amino-3-hydroxy-3-(3,4-dihydroxyphenyl)propanoic acid
(-)-(2S,3R)-2-Amino-3-hydroxy-3-(3,4-dihydroxyphenyl)propionic acid
(-)-threo-3-(3,4-Dihydroxyphenyl)-L-serine
(2RS,3RS)-2-AMINO-3-(3,4-DIHYDROXY-PHENYL)-3-HYDROXY-PROPIONIC ACID
(2RS,3RS)-2-Amino-3-(3,4-dihydroxy-phenyl)-3-hydroxy-propionic acid;DL-DOPS;DL-Droxidopa
(2RS,3RS)-2-AMINO-3-(3,4-DIhydroxyphenyl)-3-HYDROXY-propanoic acid
(2S,3R)-2-amino-3-(3,4-dihydroxyphenyl)-3-hydroxypropanoic acid
(2S,3R)-2-Amino-3-(3,4-dihydroxyphenyl)-3-hydroxypropionic Acid
(2S,3R)-3,4-dihydroxy-phenylserine
(betaR)-beta,3-dihydroxy-L-tyrosine
1-14-00-00685 (Beilstein Handbook Reference)
23651-95-8
23651-95-8,1260173-94-1(HCl)
3,4-Dihydroxyphenylserine
3916-18-5
43160-12-9
492-46-6
916A185
AB01566868_01
AC1L3P81
AC1Q5QIU
AK-86903
AKOS015889899
AM009164
ANW-57465
API0002500
AX8126964
BC214748
BDBM50103611
beta,3-Dihydroxy-DL-tyrosine threo-
BRN 2852792
CCG-222060
CHEBI:31524
CHEMBL2103827
CS-2468
CTK8B7488
D,L-(3,4-Dihydroxyphenyl)serine
D01277
D0I3RO
D4235
DB06262
DL-threo-|A-(3,4-Dihydroxyphenyl)serine
DL-threo-3-(3,4-Dihydroxyphenyl)serine
DL-threo-3,4-Dihydroxyphenylserine
DL-threo-beta-(3,4-Dihydroxyphenyl)serine
DL-threo-Dihydroxyphenylserine
DL-threo-DOPS
DL-threo-Droxidopa
DL-Tyrosine, beta,3-dihydroxy-, threo-
DL-Tyrosine, beta,3-dihydroxy-, threo- (9CI)
DOPS
Dops (TN)
droxidopa
Droxidopa (JP17/INN)
Droxidopa (L-DOPS,SM-5688)
Droxidopa (L-DOPS)
Droxidopa (L-threo-3-(3,4-Dihydroxyphenyl)serine)
Droxidopa [Latin]
Droxidopa [USAN:INN:JAN]
droxidopum
EINECS 223-480-5
FT-0651749
FT-0667809
GTPL7391
H-DL--(3,4-Dihydroxyphenyl)-DL-Ser-OH
H-DL-b-(3,4-Dihydroxyphenyl)-DL-Ser-OH
HY-13458
J7A92W69L7
KB-206605
KB-62702
KS-00000ZU4
L-dihydroxyphenylserine
L-DOPS
L-DOPS, >=98% (HPLC)
L-threo 3,4-Dihydroxyphenylserine
L-threo DOPS
L-threo-3-(3,4-Dihydroxyphenyl)serine
L-threo-3,4-dihydroxyphenylserine
L-threo-dihydroxyphenylserine
L-threo-DOPS
L-Threodops
L-Tyrosine, beta,3-dihydroxy-, (beta-R)- (9CI)
L-Tyrosine, beta,3-dihydroxy-, threo-
LS-145005
MFCD00004266
MolPort-006-115-789
Norethra
Northera (TN)
Q-201050
QXWYKJLNLSIPIN-JGVFFNPUSA-N
s3041
SBB063961
SCHEMBL134299
Serine, 3-(3,4-dihydroxyphenyl)-, DL-threo-
Serine, 3-(3,4-dihydroxyphenyl)-, L-threo-
SM 5688
SM-5688
SR-01000883755
SR-01000883755-1
TC-146210
threo-2-Amino-3-(3,4-dihydroxyphenyl)-3-hydroxypropionic acid
threo-b,3-dihydroxy-l-tyrosine
threo-beta,3-Dihydroxy-DL-tyrosine
threo-Dopaserine
UNII-24A0V01WKS component QXWYKJLNLSIPIN-JGVFFNPUSA-N
UNII-J7A92W69L7
ZINC1482049

US Patents and Regulatory Information for NORTHERA

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lundbeck Na Ltd NORTHERA droxidopa CAPSULE;ORAL 203202-001 Feb 18, 2014 RX Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Lundbeck Na Ltd NORTHERA droxidopa CAPSULE;ORAL 203202-002 Feb 18, 2014 RX Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Lundbeck Na Ltd NORTHERA droxidopa CAPSULE;ORAL 203202-001 Feb 18, 2014 RX Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Lundbeck Na Ltd NORTHERA droxidopa CAPSULE;ORAL 203202-002 Feb 18, 2014 RX Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Lundbeck Na Ltd NORTHERA droxidopa CAPSULE;ORAL 203202-003 Feb 18, 2014 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Lundbeck Na Ltd NORTHERA droxidopa CAPSULE;ORAL 203202-003 Feb 18, 2014 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
Cipla
Covington
Fuji
Accenture
Farmers Insurance
Merck
Healthtrust
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.